Tradestie Institutional Equity Comparison Engine

CCCC vs SANA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CCCC Overall Edge

CCCC Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C4 Therapeutics, Inc. (CCCC) driven by superior Momentum & Technical, Options & Structure while SANA counters with relative strength in Growth & Margin. Fundamentally, CCCC trades at N/M Forward P/E with -315.9% operating margin (-24.6% YoY revenue) versus SANA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CCCC N/M vs SANA N/M Fwd P/E
Growth & Margin Winner SANA
Op Margin -315.9% vs 0.0% ยท YoY -24.6% vs +0.0%
Momentum & Technical Winner CCCC
1Y +8.2% vs -48.6% ยท 52W Pos 28% vs 1%
Options & Structure Winner CCCC
BREAKDOWN (3rd %ile IV) vs BREAKDOWN (4th %ile IV)
CCCC NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.65
-3.99% 1D
Market Cap $362.4M
1M Return -4.16%
1Y Return +8.16%
Forward P/E N/M
Unified AI Score
57.2 / 100 HOLD
Tech 35.0 Fund 52.0 Flow 68.0 Mom 60.0
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CCCC +8.16% SANA -48.63% Spread: +56.79 pp (CCCC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CCCC TTM Op. Margin: -315.9% SANA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCCC vs SANA. Trailing 12-month operating profitability (CCCC -315.9% vs SANA 0.0%) and valuation multiples (CCCC N/M vs SANA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CCCC (4) vs SANA (4)
Institutional Metric CCCC SANA Criterion Row Winner
Market Capitalization Scale $362.4M $605.3M Larger Scale SANA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -24.6% +0.0% Higher Growth SANA
Operating Margin (TTM) Profitability -315.9% 0.0% Higher Margin SANA
Net Profit Margin Profitability -282.2% 0.0% Higher Margin SANA
Return on Equity (ROE) Capital Efficiency -47.6% -79.5% Higher ROE CCCC
52-Week Range Position Momentum 28% ($2โ€“$5) 1% ($2โ€“$5) Stronger Trend CCCC
Beta / 30D Volatility Risk Regime 1.46ฮฒ ยท 69% Vol 1.82ฮฒ ยท 78% Vol Lower Realized Risk CCCC
Unified Institutional Score Composite Signal 57.2 / 100 (HOLD) 44.3 / 100 (HOLD) Higher Composite CCCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CCCC vs SANA Buy Guide
CCCC BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live CCCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CCCC nor SANA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.